Islet Sciences Appoints Dr. Eitan Akirav to Scientific Advisory Board  
3/27/2013 8:24:38 AM

Islet Sciences, Inc., (OTC.BB: ISLT) a biotechnology company engaged in development and commercialization of patented technologies for the next generation of therapy for persons with Diabetes, today announced that Dr. Eitan Akirav has joined its Scientific Advisory Board.